PDM: MNT and Anthropometric Outcomes (2022-23)
Author and Year:
                            
                                Weinhold K, Miller C, Marrero D, et al. 2015 
                            
                        
                
                            PubMed ID:
                            
                        
                
                            Article Title:
                            
                                A Randomized Controlled Trial Translating the Diabetes Prevention Program to a University Worksite, Ohio, 2012-2014. 
                            
                        
                
                            Authors:
                            
                                Weinhold K, Miller C, Marrero D, Nagaraja H, Focht B, Gascon G 
                            
                        
                
                            Journal:
                            
                                Preventing Chronic Disease 
                            
                        
                
                            Year of publication:
                            
                                2015 
                            
                        
                
                            Volume:
                            
                                12 
                            
                        
                
                            Issue:
                            Page numbers:
                            
                                E210 
                            
                        
                
                            Study Design:
                            
                                Randomized Controlled Trial 
                            
                        
                
                            Risk of Bias Assessment Rating:
                             Some concerns
 
                                    Some concerns 
                            Inclusion Criteria:
                            
                                Eligibility criteria included being an employee aged 18 to 65 and having a body mass index (BMI) of 25.0 to 50.0 kg/m2 and prediabetes. The 7-item American Diabetes Association risk assessment questionnaire was administered to determine risk for type 2 diabetes, and those with a score of 5 or more were classified as potentially eligible and screened for any exclusionary criteria. Eligible participants had fasting finger-stick glucose levels of 100 to 125 mg/dL, indicative of prediabetes. Individuals with fast-ing glucose levels of 95 to 99 mg/dL or 126 to 140 mg/dL completed a second finger stick to assess hemoglobin A1c (HbA1c); HbA1c levels of 5.7% to 6.4% indicated prediabetes and study eligibility. 
                            
                        
                
                            Exclusion Criteria:
                            
                                Individuals with HbA1c or glucose levels above the indicated ranges were advised to see their physician and excluded from participation. 
                            
                        
                
                            Research Purpose:
                            
                                This study evaluated the efficacy of a worksite lifestyle intervention on metabolic and behavioral risk factors compared with usual care. 
                            
                        
                
                            Blinding efforts:
                            
                                Not blinded 
                            
                        
                
                            Study Location:
                            
                                Columbus, Ohio, USA 
                            
                        
                
                            Source(s) of Funding:
                            
                                Not-for-profit 
                            
                        
                
                            Please specify names of funders:
                            
                                National Institute of Diabetes and Digestive and Kidney Diseases 
                            
                        


